Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Validates Agencourt’s AMPure System for Use With SNP Array 5.0

NEW YORK (GenomeWeb News) — Agencourt Bioscience said today that Affymetrix has validated its PCR target-preparation system for use with its new SNP Array 5.0.
 
Lynn Doucette-Stamm, Agencourt’s vice president of business development, said the validation is confirmation that its AMPure system is ”adaptable to manual and automated methods for SNP genotyping applications."
 
The purification system is based on Solid Phase Reversible Immobilization, which is used with automated purification methods on Beckman Coulter’s lab workstations, Agencourt said.
 
Agencourt, a Beckman Coulter subsidiary, said Affy’s Genome-Wide Human SNP Array 5.0 is currently being used to study autism, bipolar disease, cancer, diabetes, and heart disease.
 

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.